These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15204676)

  • 1. Processes of care during a randomized trial of office-based treatment of opioid dependence in primary care.
    Fiellin DA; O'Connor PG; Chawarski M; Schottenfeld RS
    Am J Addict; 2004; 13 Suppl 1():S67-78. PubMed ID: 15204676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone maintenance in primary care: a randomized controlled trial.
    Fiellin DA; O'Connor PG; Chawarski M; Pakes JP; Pantalon MV; Schottenfeld RS
    JAMA; 2001 Oct; 286(14):1724-31. PubMed ID: 11594897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.
    King VL; Kidorf MS; Stoller KB; Schwartz R; Kolodner K; Brooner RK
    J Subst Abuse Treat; 2006 Dec; 31(4):385-93. PubMed ID: 17084792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients.
    Jones ES; Moore BA; Sindelar JL; O'Connor PG; Schottenfeld RS; Fiellin DA
    Drug Alcohol Depend; 2009 Jan; 99(1-3):132-40. PubMed ID: 18804923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public policy statement on Office-Based Opioid Agonist Treatment (OBOT).
    J Addict Dis; 2005; 24(3):153-61. PubMed ID: 16186090
    [No Abstract]   [Full Text] [Related]  

  • 6. Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services.
    Whitley SD; Kunins HV; Arnsten JH; Gourevitch MN
    J Subst Abuse Treat; 2007 Jul; 33(1):85-90. PubMed ID: 17588493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?
    Sullivan LE; Chawarski M; O'Connor PG; Schottenfeld RS; Fiellin DA
    Drug Alcohol Depend; 2005 Jul; 79(1):113-6. PubMed ID: 15943950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women and opioid dependence treatment: office-based versus opioid treatment program-based care?
    Jones ES; Fiellin DA
    Subst Abus; 2007 Jun; 28(2):3-8. PubMed ID: 19266708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinic-based treatment for opioid dependence: a qualitative inquiry.
    McMurphy S; Shea J; Switzer J; Turner BJ
    Am J Health Behav; 2006; 30(5):544-54. PubMed ID: 16893317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary care patient characteristics associated with completion of 6-month buprenorphine treatment.
    Neumann AM; Blondell RD; Azadfard M; Nathan G; Homish GG
    Addict Behav; 2013 Nov; 38(11):2724-8. PubMed ID: 23934003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone therapy for opioid dependence.
    Krambeer LL; von McKnelly W; Gabrielli WF; Penick EC
    Am Fam Physician; 2001 Jun; 63(12):2404-10. PubMed ID: 11430455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost.
    Avants SK; Margolin A; Sindelar JL; Rounsaville BJ; Schottenfeld R; Stine S; Cooney NL; Rosenheck RA; Li SH; Kosten TR
    Am J Psychiatry; 1999 Jan; 156(1):27-33. PubMed ID: 9892294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment.
    Fingerhood MI; King VL; Brooner RK; Rastegar DA
    Subst Abus; 2014; 35(2):122-6. PubMed ID: 24821346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment options for opiate addiction.
    J Ky Med Assoc; 2004 May; 102(5):221-4. PubMed ID: 15152448
    [No Abstract]   [Full Text] [Related]  

  • 15. Provider satisfaction with office-based treatment of opioid dependence: a systematic review.
    Becker WC; Fiellin DA
    Subst Abus; 2005 Mar; 26(1):15-22. PubMed ID: 16492659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial.
    Robertson JR; Raab GM; Bruce M; McKenzie JS; Storkey HR; Salter A
    Addiction; 2006 Dec; 101(12):1752-9. PubMed ID: 17156174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provision of methadone treatment in primary care medical practices: review of the Scottish experience and implications for US policy.
    Weinrich M; Stuart M
    JAMA; 2000 Mar; 283(10):1343-8. PubMed ID: 10714738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine 101: treating opioid dependence with buprenorphine in an office-based setting.
    Torrington M; Domier CP; Hillhouse M; Ling W
    J Addict Dis; 2007; 26(3):93-9. PubMed ID: 18018812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence.
    Turner BJ; Laine C; Lin YT; Lynch K
    Arch Intern Med; 2005 Aug 8-22; 165(15):1769-76. PubMed ID: 16087826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine for heroin addicts: the issue of illicit opioid abuse during maintenance.
    Cho E; Dermatis H; Galanter M
    Subst Abus; 2006 Jun; 27(1-2):1-3. PubMed ID: 17062539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.